FDA inspection
Guangxi Yulin Pharmaceutical Group Co. Ltd.: FDA inspection ending Sep 29, 2016
FDA inspection 992915 · Voluntary Action Indicated (VAI) · Yulin
Key facts
| Inspection ID | 992915 |
|---|---|
| Firm | Guangxi Yulin Pharmaceutical Group Co. Ltd. |
| FEI number | 1000589993 |
| Address | 1 Chengzhan Road |
| City | Yulin |
| Country | China |
| Fiscal year | 2016 |
| Inspection end date | Sep 29, 2016 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data